Kirkin AF - Search Results

1

Aberrant p27Kip1 promoter methylation in malignant melanoma.

Worm J, Bartkova J, Kirkin AF, Straten P, Zeuthen J, Bartek J, Guldberg P. Worm J, et al. Among authors: kirkin af. Oncogene. 2000 Oct 19;19(44):5111-5. doi: 10.1038/sj.onc.1203891. Oncogene. 2000. PMID: 11042700

2

Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines.

Kirkin AF, Petersen TR, Olsen AC, Li L, thor Straten P, Zeuthen J. Kirkin AF, et al. Cancer Immunol Immunother. 1995 Aug;41(2):71-81. doi: 10.1007/BF01527402. Cancer Immunol Immunother. 1995. PMID: 7656272 Free PMC article.

3

A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses.

Olsen AC, Fossum B, Kirkin AF, Zeuthen J, Gaudernack G. Olsen AC, et al. Among authors: kirkin af. Scand J Immunol. 1995 Apr;41(4):357-64. doi: 10.1111/j.1365-3083.1995.tb03579.x. Scand J Immunol. 1995. PMID: 7899823

4

Differential modulation by interferon gamma of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigens.

Kirkin AF, thor Straten P, Zeuthen J. Kirkin AF, et al. Cancer Immunol Immunother. 1996 May;42(4):203-12. doi: 10.1007/s002620050272. Cancer Immunol Immunother. 1996. PMID: 8665567 Free PMC article.

5

The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.

Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J. Bartkova J, et al. Among authors: kirkin af. Cancer Res. 1996 Dec 1;56(23):5475-83. Cancer Res. 1996. PMID: 8968104

6

Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines.

Thor Straten P, Kirkin AF, Seremet T, Zeuthen J. Thor Straten P, et al. Among authors: kirkin af. Int J Cancer. 1997 Mar 4;70(5):582-6. doi: 10.1002/(sici)1097-0215(19970304)70:5<582::aid-ijc15>3.0.co;2-f. Int J Cancer. 1997. PMID: 9052759 Free article.

7

Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3.

Halder T, Pawelec G, Kirkin AF, Zeuthen J, Meyer HE, Kun L, Kalbacher H. Halder T, et al. Among authors: kirkin af. Cancer Res. 1997 Aug 1;57(15):3238-44. Cancer Res. 1997. PMID: 9242455

8

Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.

Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J. Guldberg P, et al. Among authors: kirkin af. Cancer Res. 1997 Sep 1;57(17):3660-3. Cancer Res. 1997. PMID: 9288767

9

Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma.

Guldberg P, Kirkin AF, Gronbaek K, thor Straten P, Ahrenkiel V, Zeuthen J. Guldberg P, et al. Among authors: kirkin af. Int J Cancer. 1997 Sep 4;72(5):780-3. doi: 10.1002/(sici)1097-0215(19970904)72:5<780::aid-ijc13>3.0.co;2-d. Int J Cancer. 1997. PMID: 9311594 Free article.

10

In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele.

Real LM, Jimenez P, Cantón J, Kirkin A, García A, Abril E, Zeuthen J, Ruiz-Cabello F, Garrido F. Real LM, et al. Int J Cancer. 1998 Jan 19;75(2):317-23. doi: 10.1002/(sici)1097-0215(19980119)75:2<317::aid-ijc23>3.0.co;2-8. Int J Cancer. 1998. PMID: 9462725 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page